Beyond Air Misses Reduced FY26 Revenue Guidance, Deepening Execution Concerns

What happened

Beyond Air reported full-year FY26 revenue of $7.7 million, up 107% YoY but below the previously reduced guidance range of $8-10 million, indicating that the expected H2 acceleration did not materialize. The Q4 revenue of approximately $2.1 million (implied from YoY 66% growth) suggests the company failed to reach the $2.2-3.2 million quarterly pace needed to hit the lowered target. This miss reinforces the narrative of slow hospital adoption, lumpy revenue, and persistent negative gross margins that plagued FY26. With cash burn still high at ~$4.7 million per quarter and the company reliant on expensive debt and a dilutive equity line, the runway extension comes at a steep cost to shareholders. The results validate the bear case in the DeepValue report, where revenue stalls near $6-8 million annually and gross margins remain negative.

Implication

Wait for evidence of sequential revenue acceleration above $2.5 million per quarter and positive gross margins before considering entry. The path to breakeven remains uncertain, and the current capital structure punishes equity holders.

Thesis delta

The FY26 revenue of $7.7 million, falling short of the already reduced $8-10 million guidance, shifts the thesis from 'wait-and-see' to 'increased probability of restructuring.' The bear case (40% probability, $0.75 implied value) appears more likely given the failure to hit the lower end of guidance. The base case now requires a step-change in execution and financing discipline that has not yet materialized.